Background-Loss of E-cadherin expression has been implicated in the development of invasive characteristics in colorectal carcinomas. Failure to express E-cadherin may result from mutations of the E-cadherin gene (HSECAD). Aims-To examine the correlation between E-cadherin expression and genetic changes at HSECAD; and to examine differences in E-cadherin expression and genetic changes at HSECAD between three different groups of colorectal cancer -replication error positive (RER+) sporadic cancers, RER-sporadic cancers and ulcerative colitis associated cancers.
Subjects and methods-Sixty eight colorectal cancers (22 RER+ sporadic cancers, 32 RER-sporadic cancers and 14 ulcerative colitis associated cancers) were studied using immunohistochemistry and for allele loss at the HSECAD locus. Exon 16 of HSECAD contains several mononucleotide repeat tracts which are very similar to microsatellite repeats and which may be susceptible to replication errors (manifest as new alleles). All cases were also examined for new alleles in exon 16. Results-Absent or decreased E-cadherin protein expression was found in 27 (38%) of 68 colorectal cancers and the pattern of expression did not differ significantly among the three tumour groups. Allele loss occurred at HSECAD in four (10%) of 40 informative cancers and there were no differences between the three subgroups. New alleles at exon 16 were detected in three (14%) of In this study we examined immunohistochemical expression of E-cadherin protein in three different types of colorectal cancer (RERsporadic colorectal cancers, RER+ sporadic colorectal cancers and ulcerative colitis associated colorectal cancers). As a means of analysing E-cadherin mutations, we studied allele loss at a polymorphic marker near to HSECAD in these colorectal cancers. In addition, each cancer was analysed for RERs in the poly(T) and poly(A) mononucleotide repeats in HSECAD exon 16 . The immunohistochemical and genetic data were then correlated in order to suggest whether or not mutations at HSECAD could explain the patterns of E-cadherin expression that were observed.
Methods

CASE SELECTION
We selected 68 cases of colorectal cancer from the archives of the Colorectal Cancer Unit and the Academic Department of Pathology at St Mark's Hospital for DNA analysis. Forty nine of these cases were sporadic colorectal cancers and had previously been categorised into 31 RER-and 18 RER+ cancers.34 To this group, we added a further four colorectal cancers that had been typed as RER+, one colorectal cancer typed as RER-and 14 as associated with ulcerative colitis. The RER status of the ulcerative colitis associated colorectal cancers was determined, but they were analysed without regard to their RER status in this study, in order to prevent subdivision of these cancers into small groups.
IMMUNOHISTOCHEMISTRY
Freshly cut 4 ,um sections of formalin fixed, paraffin wax embedded tissue were analysed using immunohistochemistry. Sections were dewaxed in xylene and re-hydrated through graded alcohols. Endogenous peroxidase activity was blocked by incubation for 15 minutes in 0-5% hydrogen peroxide in methanol. Antigen retrieval was by heating these sections in a pressure cooker at 15 (Fig 1) and this was used as an internal positive control. Most tumours showed heterogeneous staining with variable degrees of both membrane and cytoplasmic staining (Fig 2) . In some areas, there was intense cytoplasmic staining with no membrane staining and a few cases were negative for both cytoplasmic and membrane staining. Those cases which showed membrane staining in over 25% of tumour cells were regarded as positive for E-cadherin expression. Cytoplasmic staining, in the absence of membrane staining, was regarded as negative, as membrane localisation is essential for E-cadherin function. Ten (31%) of 32 RER-tumours, 10 (45%) of 22 RER+ tumours and six (43%) of 14 ulcerative colitis associated colorectal cancers were negative for E-cadherin expression. There was a trend for reduced expression in the RER+ tumours compared with either RER-tumours or ulcerative colitis associated colorectal cancers, but this was not statistically significant (Table I ). The pattern of expression of E-cadherin was broadly similar in all tumour grades (Table II) . The results of the PCR for allele loss at D16S520 are shown in Table III Non-informative 11 9 8 28 Association X22 (allele loss v no allele loss) 0, p>0.9.
UC=ulcerative colitis. 
